NCT05885282 Investigation of the Effects of Local Vibration Applied to Different Regions and Spinal Stabilization Exercises Status COMPLETED Phase NA
NCT05881122 Anti-inflammatory Diet Consultation for Those With Neuromuscular Disability Status COMPLETED Phase NA
NCT05880745 The Effect of the Level of Hand Fatigability on Multiple Sclerosis on General Fatigue and Functionality Status COMPLETED Phase NA
NCT05878873 The Neural Mechanisms of Split-belt Treadmill Adaptation in People With Multiple Sclerosis Status COMPLETED Phase NA
NCT05870254 Exergaming With Immersive Virtual Reality For People With Multiple Sclerosis (ExeRVIEM) Status COMPLETED Phase NA
NCT05865405 A Closed Loop, Doctor to Patient, Mobile Application for Depression in People With Multiple Sclerosis Status ACTIVE_NOT_RECRUITING Phase NA
NCT05859802 Effects of Physical Therapy and Dalfampridine on Functional Mobility in Non Ambulatory Persons With Multiple Sclerosis Status COMPLETED Phase PHASE2/PHASE3
NCT05853835 First-in-Human Trial in Healthy Adult Volunteers to Evaluate Safety, Tolerability and PK of LAPIX Study Drug; LPX-TI641 Status COMPLETED Phase PHASE1
NCT05849467 Central Nervous System Uptake of Anti-CD8+ T Cell Minibodies in Multiple Sclerosis and Progressive Multifocal Leukoencephalopathy Status RECRUITING Phase PHASE1
NCT05848323 Prospective Case Series to Refine Standalone Cognitive Behavioral Therapy Components for Multiple Sclerosis Fatigue Status COMPLETED Phase NA
NCT05835622 Clinical Investigation of the Quality of Life Benefit of Using a Home Walking Exoskeleton for a Population of Multiple Sclerosis Patients. Status RECRUITING Phase NA
NCT05834855 Non-inferiority Study of Rituximab Compared to Ocrelizumab in Relapsing MS Status RECRUITING Phase PHASE3
NCT05834335 Protection Against Severe Coronavirus Disease 2019 in Patients With Multiple Sclerosis Stratified According to Disease Modifying Treatment Status COMPLETED Phase N/A
NCT05832515 AHSCT With Fludarabine and Cyclophosphamide Based Conditioning Regimes in Patients With Multiple Sclerosis Status RECRUITING Phase PHASE1
NCT05828901 Predicting Disease Activity and Rebound Risk in MS Patients Treated With Sphingosine-1-phosphate Receptor Modulators (S1PRM) Status TERMINATED Phase N/A